General Medicine and Primary Care

Host: Peter Buch, MD, FACG, AGAF, FACP

Guest: Nicole Hanley-Williams, MD

The management of motility disorders like achalasia and gastroparesis can be very complex for both patients and clinicians alike. Fortunately, there have been several advancements in the evaluation and treatment of these disorders. Joining Dr. Peter Buch to walk us through what those developments are and how they can help improve our patients’ quality of life is Dr. Nicole Hanley-Williams, who specializes in motility and functional disorders at Beth Israel Lahey Health.

Host: Jennifer Caudle, DO

Guest: John Russell, MD

As clinicians on the frontlines of the COVID-19 pandemic, we’re among the first to hear about our patients’ fears of the vaccines’ validity and safety. So how can we help address their concerns? ReachMD hosts Dr. Jennifer Caudle and Dr. John Russell sit down together to talk about how we can counsel patients who may be hesitant to receive the COVID-19 vaccine.

Published March 16, 2021

Host: Jennifer Caudle, DO

Guest: Paul Jarris, MD, MBA

Since the COVID-19 vaccines received an emergency use authorization, tracking possible adverse reactions in real time becomes even more important. But what are some of the limitations we’re facing in doing so, and how can we overcome them? To find out, Dr. Jennifer Caudle speaks with Dr. Paul Jarris, Chief Medical Advisor for MITRE Corporation.

Host: Peter Buch, MD, FACG, AGAF, FACP

Guest: Philip Ginsburg, MD

With so many treatment options currently available for moderate to severe Crohn’s disease and ulcerative colitis, how do you know which one will work best for your patients? Joining Dr. Peter Buch to help answer that and other questions is Dr. Philip Ginsburg, Medical Director of Research and the Director of the Inflammatory Bowel Disease Center of Connecticut.

Host: Jerome Lisk, MD, MBA, M.S., FAAN

Guest: Eric Gantwerker, MD, MMSc, FACS

The rise of gaming in medical education has become a much bigger and faster-moving phenomenon than we may know. To find out more, Dr. Jerome Lisk is joined by Dr. Eric Gantwerker from Level EX, which develops video games that are designed to improve clinical decision-making skills. Together, they talk about the evolving role of video games in healthcare settings and why we may be pressing play sooner than we think.

Host: Peter Buch, MD, FACG, AGAF, FACP

Guest: Philip Ginsburg, MD

Tofacitinib is a common treatment option for patients with ulcerative colitis. But it’s not without its risks. Here to share what we need to consider before we start our patients on tofacitinib is Dr. Philip Ginsburg, Medical Director of Research and the Director of the Inflammatory Bowel Disease Center of Connecticut.

Host: Hector O. Chapa, MD, FACOG

Guest: Joshua D. Lee MD, MSc

Dr. Hector Chapa and Dr. Joshua Lee discuss the status of opiate use and what we can do to turn things around.

Host: Peter Buch, MD, FACG, AGAF, FACP

Guest: Jeffrey Basile, MD

Now that we have therapies like vedolizumab and ustekinumab, many are wondering if there’s still a role for anti-TNFs in the treatment of IBD. Here to share his perspective and how he uses the multitude of available treatment options to his advantage is Dr. Jeffrey Basile, a gastroenterologist from Charleston GI.

Host: Andrew Wilner, MD, FACP, FAAN

Guest: Ken Tyler, MD

To find out what we currently know about the neurological complications caused by COVID-19, Dr. Andrew Wilner speaks with Dr. Ken Tyler, Professor and Chair of the Department of Neurology at the University of Colorado School of Medicine.

Host: Peter Buch, MD, FACG, AGAF, FACP

Guest: Jeffrey Basile, MD

The treatment and evaluation of inflammatory bowel disease, or IBD, is continuously changing to provide the best quality of care for patients. Dr. Peter Buch is joined by Dr. Jeffrey Basile, a gastroenterologist from Charleston GI, to shed some light on the latest treatment options for IBD patients.